Literature DB >> 20633318

How can female germline stem cells contribute to the physiological neo-oogenesis in mammals and why menopause occurs?

Antonin Bukovsky1.   

Abstract

At the beginning of the last century, reproductive biologists have discussed whether in mammalian species the fetal oocytes persist or are replaced by neo-oogenesis during adulthood. Currently the prevailing view is that neo-oogenesis is functional in lower vertebrates but not in mammalian species. However, contrary to the evolutionary rules, this suggests that females of lower vertebrates have a better opportunity to provide healthy offspring compared to mammals with oocytes subjected to environmental threats for up to several decades. During the last 15 years, a new effort has been made to determine whether the oocyte pool in adult mammals is renewed as well. Most recently, Ji Wu and colleagues reported a production of offspring from female germline stem cells derived from neonatal and adult mouse ovaries. This indicates that both neonatal and adult mouse ovaries carry stem cells capable of producing functional oocytes. However, it is unclear whether neo-oogenesis from ovarian somatic stem cells is physiologically involved in follicular renewal and why menopause occurs. Here we review observations that indicate an involvement of immunoregulation in physiological neo-oogenesis and follicular renewal from ovarian stem cells during the prime reproductive period and propose why menopause occurs in spite of persisting ovarian stem cells.

Entities:  

Mesh:

Year:  2010        PMID: 20633318     DOI: 10.1017/S143192761000036X

Source DB:  PubMed          Journal:  Microsc Microanal        ISSN: 1431-9276            Impact factor:   4.127


  8 in total

1.  Detection, characterization, and spontaneous differentiation in vitro of very small embryonic-like putative stem cells in adult mammalian ovary.

Authors:  Seema Parte; Deepa Bhartiya; Jyoti Telang; Vinita Daithankar; Vinita Salvi; Kusum Zaveri; Indira Hinduja
Journal:  Stem Cells Dev       Date:  2011-03-23       Impact factor: 3.272

Review 2.  Immunoregulation of follicular renewal, selection, POF, and menopause in vivo, vs. neo-oogenesis in vitro, POF and ovarian infertility treatment, and a clinical trial.

Authors:  Antonin Bukovsky; Michael R Caudle
Journal:  Reprod Biol Endocrinol       Date:  2012-11-23       Impact factor: 5.211

3.  Markers of stem cells in human ovarian granulosa cells: is there a clinical significance in ART?

Authors:  Michail Varras; Theodora Griva; Vasileios Kalles; Christodoulos Akrivis; Nikolaos Paparisteidis
Journal:  J Ovarian Res       Date:  2012-11-20       Impact factor: 4.234

4.  Stimulation of ovarian stem cells by follicle stimulating hormone and basic fibroblast growth factor during cortical tissue culture.

Authors:  Seema Parte; Deepa Bhartiya; Dhananjay D Manjramkar; Anahita Chauhan; Amita Joshi
Journal:  J Ovarian Res       Date:  2013-04-01       Impact factor: 4.234

5.  Novel methods of treating ovarian infertility in older and POF women, testicular infertility, and other human functional diseases.

Authors:  Antonin Bukovsky
Journal:  Reprod Biol Endocrinol       Date:  2015-02-25       Impact factor: 5.211

6.  Differential expression of pluripotent and germ cell markers in ovarian surface epithelium according to age in female mice.

Authors:  Bo Sun Joo; In Kook Jung; Min Jung Park; Jong Kil Joo; Ki Hyung Kim; Kyu-Sup Lee
Journal:  Reprod Biol Endocrinol       Date:  2014-11-24       Impact factor: 5.211

Review 7.  Very small embryonic-like stem cells: implications in reproductive biology.

Authors:  Deepa Bhartiya; Sreepoorna Unni; Seema Parte; Sandhya Anand
Journal:  Biomed Res Int       Date:  2013-02-13       Impact factor: 3.411

Review 8.  Germline cells in ovarian surface epithelium of mammalians: a promising notion.

Authors:  Onder Celik; Ebru Celik; Ilgin Turkcuoglu; Ercan Yilmaz; Yavuz Simsek; Bulent Tiras
Journal:  Reprod Biol Endocrinol       Date:  2012-12-17       Impact factor: 5.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.